Filana Therapeutics (FLNA) Change in Acquisitions & Divestments (2010 - 2017)
Filana Therapeutics (FLNA) posted quarterly Change in Acquisitions & Divestments of $2.1 million for Q1 2017, up 281.82% quarter-over-quarter from $550000.0 in Q4 2016.
Filana Therapeutics (FLNA) Change in Acquisitions & Divestments (2010 - 2017) Analysis & Trends
Filana Therapeutics' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2017.
- In Q1 2017, Change in Acquisitions & Divestments changed N/A year-over-year to $2.1 million; the TTM figure through Dec 2017 stood at $2.1 million (down 12.5% YoY), while the FY2017 annual figure was $2.1 million, up 2.44% from the prior year.
- Change in Acquisitions & Divestments for Q1 2017 stood at $2.1 million, up from $550000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $6.9 million in Q1 2013, with the low at $250000.0 in Q3 2014.
- The 5-year median for Change in Acquisitions & Divestments is $1.2 million (2014), against an average of $1.7 million.
- The sharpest annual moves came in 2013 and 2015: Change in Acquisitions & Divestments plunged 91.22% in 2013, then jumped 280.0% in 2015.
- Filana Therapeutics' Change in Acquisitions & Divestments stood at $1.3 million in 2013, then decreased by 15.38% to $1.1 million in 2014, then dropped by 18.18% to $900000.0 in 2015, then slumped by 38.89% to $550000.0 in 2016, then surged by 281.82% to $2.1 million in 2017.
- Business Quant data shows FLNA's Change in Acquisitions & Divestments at $2.1 million in Q1 2017, $550000.0 in Q4 2016, and $900000.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Filana Therapeutics | 46.00 Mn | 46.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 2.10 Mn |
| Mar 31, 2017 | 2.10 Mn |
| Dec 31, 2016 | 550,000.00 |
| Dec 31, 2016 | 550,000.00 |
| Dec 31, 2015 | 900,000.00 |
| Dec 31, 2015 | 900,000.00 |
| Sep 30, 2015 | 950,000.00 |
| Sep 30, 2015 | 950,000.00 |
| Dec 31, 2014 | 1.10 Mn |
| Dec 31, 2014 | 1.10 Mn |
| Sep 30, 2014 | 250,000.00 |
| Sep 30, 2014 | 250,000.00 |
| Jun 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.25 Mn |
| Mar 31, 2014 | 1.25 Mn |
| Mar 31, 2014 | 1.25 Mn |
| Dec 31, 2013 | 1.30 Mn |
| Dec 31, 2013 | 1.30 Mn |
| Sep 30, 2013 | 1.30 Mn |
| Sep 30, 2013 | 1.30 Mn |